Recruitment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

American Journal of Cardiology

Volumn 99, Issue 12 SUPPL., 2007, Pages

  Kingry, Connie ^a   Bastien, Arnaud ^b   Booth, Gillian ^c   Geraci, Therese S ^d   Kirpach, Brenda R ^e   Lovato, Laura C ^f   Margolis, Karen L ^h   Rosenberg, Yves ^g   Sperl Hillen, JoAnne M ^e   Vargo, Laura ⁱ   Williamson, Jeff D ^f   Probstfield, Jeffrey L ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b Department of Anesthesiology   (United States)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Berman Center for Outcomes and Clinical Research   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h HENNEPIN COUNTY MEDICAL CENTER   (United States)

ⁱ CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SCREENING; UNITED STATES;

CANADA; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; PATIENT SELECTION; UNITED STATES;

EID: 34250786787     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.025     Document Type: Article

References (27)

1. Probstfield J.L., Wittes J.T., and Hunninghake D.B. Recruitment in NHLBI population-based studies and clinical trials: data analysis and survey results. Control Clin Trials 8 (1987) 141S-149S
2. Staessen J.A., Fagard R., Thijs L., Celis H., Arabidze G.G., Birkenhager W.H., Bulpitt C.J., de Leeuw P.W., Dollery C.T., Fletcher A.E., et al., Systolic Hypertension in Europe (Syst-Eur) trial investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350 (1997) 757-764
3. Petrovitch H., Byington R., Bailey G., Borhani P., Carmody S., Goodwin L., Johnson A., Johnson P., Jones M., Levin J., Sugars C., and Probstfield J.L. Screening and recruitment experience in the full scale SHEP trial. Hypertension 17 (1991) II16-II23
4. Pressel S., Davis B.R., Louis G.T., Whelton P., Adrogue H., Egan D., Farber M., Payne G., Probstfield J.L., Ward H., and ALLHAT Research Group. Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Control Clin Trials 22 (2001) 674-686
5. Gerstein H.C., and DREAM Investigators. Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial. Diabetologia 47 (2004) 1519-1527
6. Teo K., and ONTARGET/TRANSCEND Investigators. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Am Heart J 148 (2004) 52-61 1
7. Cook E.D., Moody-Thomas S., Anderson K.B., Campbell R., Hamilton S.J., Harrington J.M., Lippman S.M., Minasian L.M., Paskett E.D., Craine S., Arnold K.B., and Probstfield J.L. Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Clin Trials 2 (2005) 436-442
8. Goff D.C., Gerstein H.C., Ginsberg H.N., Cushman W.C., Margolis K.L., Byington R.P., Buse J.B., Genuth S., Probstfield J.L., Simons-Morton D.G., and ACCORD Study Group. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 99 suppl (2007) 4i-20i
9. ACCORD Study Group. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol 99 suppl (2007) 21i-33i
10. Gerstein H.C., Riddle M.C., Kendall D.M., Cohen R.M., Goland R., Feinglos M.N., Kirk J.K., Hamilton B.P., Ismail-Beigi F., Feeney P., and ACCORD Study Group. Glycemia treatment strategies in the ACCORD trial. Am J Cardiol 99 suppl (2007) 34i-43i
11. Cushman W.C., Grimm R.H., Cutler J.A., Evans G.W., Capes S., Corson M.A., Sadler L.S., Alderman M.H., Peterson K., Bertoni A., Basile J.N., and ACCORD Study Group. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 99 suppl (2007) 44i-55i
12. Ginsberg H.N., Bonds D.E., Lovato L.C., Crouse J.R., Elam M.B., Linz P.E., O'Connor P.J., Leiter L.A., Weiss D., Lipkin E., Fleg J.L., and ACCORD Study Group. Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 99 suppl (2007) 56i-67i
13. Lusk C.M., Carroll L., Egan D., Kingry C., Johnson J., Sullivan S., Nwachuku C., Probstfield J.L., and ALLHAT Collaborative Research Group. The development and impact of a retention and adherence program in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)-the adherence survival kit. Appl Clin Trials 13 (2004) 40-48
14. Hays J., Hunt J.R., Hubbell F.A., Anderson G.A., Limacher M., Allen C., and Rossouw J.E. The Women's Health Initiative recruitment methods and results. Ann Epidemiol 13 (2003) S18-S77
15. Health Insurance Portability and Accountability Act of 1996 (HIPAA), Pub L No. 104-191 45 CFR Part 160, Part 164 Subparts A and E (1996).
16. Probstfield J.L. The clinical trial pre-randomization compliance (adherence) screen. In: Cramer J.A., and Spilker B. (Eds). Patient Compliance in Medical Practice and Clinical Trials (1991), Raven Press, New York 323-334
17. Carew B., Ahn S., Boichot H., Dierenfeldt B., Dolan N., Edens T., Weiner D., and Probstfield J.L. Recruitment in the Studies of Left Ventricular Dysfunction (SOLVD): strategies for screening and enrollment in two concurrent but different trials. Control Clin Trials 13 (1992) 325-338
18. Lovato L., Hill K., Hertert S., Hunninghake D.B., and Probstfield J.L. Recruitment for controlled clinical trials: summary and annotated bibliography. Control Clin Trials 18 (1997) 328-357
19. Agras W.S., Marshall G.D., and Kraemer H.C. Planning recruitment. Circulation 66 (1982) IV54-IV58
20. Neaton J.D., Grimm Jr. R.H., and Cutler J.A. Recruitment of participants for the Multiple Risk Factor Intervention Trial (MRFIT). Control Clin Trials 8 (1987) 41S-53S
21. Quick A.M., Khaw P.T., and Elkington A.R. Problems encountered in recruiting patients to an ophthalmic drug trial. Br J Ophthalmol 73 (1989) 432-434
22. Yusuf S., Held P., and Teo K.K. Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria. Stat Med 9 (1990) 73-86
23. Cosgrove N.M., Borhani N.B., Bailey G., Borhani P., Levin J., Hoffmeier M., Kreiger S., Lovato L.C., Petrovitch H., Vogt T., et al., Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. Mass mailing and staff experience in a total recruitment program for a clinical trial: the SHEP experience. Control Clin Trials 19 (1999) 133-148
24. Hunninghake D.B., Darby C.A., and Probstfield J.L. Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials 8 (1987) 6S-30S
25. Vogt T.M., Ireland C.C., Black D., Camel G., and Hughes G. Recruitment of elderly volunteers for a multicenter clinical trial: the SHEP Pilot Study. Control Clin Trials 7 (1986) 118-133
26. Agras W.S., Bradford R.H., Hunninghake D.B., Knoke J., Marshall G.D., and McKeown M. Participant recruitment to the Coronary Primary Prevention Trial. J Chronic Dis 36 (1983) 451-465
27. Goodman G.E., Omenn G.S., Thornquist M.D., Lund B., Metch B., and Gylys-Colwell I. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers. Cancer Epidemiol Biomarkers Prev 2 (1993) 389-396